275 related articles for article (PubMed ID: 321331)
21. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
Stojan B; Hasler F
Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
[TBL] [Abstract][Full Text] [Related]
22. Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.
Srivastava LM; Agarwal DP; Goedde HW; Rohde R
Tropenmed Parasitol; 1975 Jun; 26(2):212-8. PubMed ID: 1162738
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of the immunological tests in rheumatoid arthritis.
Kim NH; Yang KH; Yang IH
Yonsei Med J; 1989; 30(1):23-9. PubMed ID: 2741472
[TBL] [Abstract][Full Text] [Related]
24. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus.
Ballou SP; Kushner I
Clin Exp Immunol; 1979 Jul; 37(1):58-67. PubMed ID: 385188
[TBL] [Abstract][Full Text] [Related]
25. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
26. [Immunoglobulins (IgG, IgA, IgM, IgE) and complement components (C3, C4 and C1-inhibitor) in chronic urticaria (author's transl)].
Wüthrich B
Dermatol Monatsschr; 1979 Mar; 165(3):191-7. PubMed ID: 467753
[No Abstract] [Full Text] [Related]
27. Immunofluorescence studies for immunoglobulins and complement C3 in synovial joint membranes in psoriatic arthritis.
Fyrand O; Mellbye OJ; Natvig JB
Clin Exp Immunol; 1977 Sep; 29(3):422-7. PubMed ID: 338220
[TBL] [Abstract][Full Text] [Related]
28. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
[TBL] [Abstract][Full Text] [Related]
29. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
[TBL] [Abstract][Full Text] [Related]
30. Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities.
Mach PS; Piatier D; Le Go A; Delbarre F
Clin Exp Immunol; 1979 May; 36(2):311-6. PubMed ID: 383333
[TBL] [Abstract][Full Text] [Related]
31. Restriction of immunoglobulin heterogeneity, autoimmunity and serum protein levels in aged people.
Riesen W; Keller H; Skvaril F; Morell A; Barandun S
Clin Exp Immunol; 1976 Nov; 26(2):280-5. PubMed ID: 62632
[TBL] [Abstract][Full Text] [Related]
32. [Immunoglobulins and complement in pregnant women with EPH gestosis (author's transl)].
Janković D; Horvat Z; Bolanca M; Barsić E
Jugosl Ginekol Opstet; 1981; 21(3-4):69-74. PubMed ID: 7339278
[TBL] [Abstract][Full Text] [Related]
33. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
Dreher R; Helmke K
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
[No Abstract] [Full Text] [Related]
34. Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis.
Nishimura S; Nishiya K; Hisakawa N; Chikazawa H; Ookubo S; Nakatani K; Hashimoto K
Acta Med Okayama; 1996 Oct; 50(5):261-5. PubMed ID: 8914679
[TBL] [Abstract][Full Text] [Related]
35. The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseases.
Chellingworth MC; Salmon M; Scott DL; Bacon PA
Rheumatol Int; 1984; 4(1):23-5. PubMed ID: 6609412
[TBL] [Abstract][Full Text] [Related]
36. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients.
Janjumratsang P; Phainupong D; Chanjanakijskul S; Roongphibulsopit P
J Dermatol; 2008 Aug; 35(8):508-13. PubMed ID: 18789071
[TBL] [Abstract][Full Text] [Related]
37. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
38. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
39. Relation of clinical activity of rheumatoid arthritis to immune complexes, complement components and anti-immunoglobulins.
Takemura S; Ueda M; Tagami H; Kato H; Yoshikawa T; Kawakami N; Kondo M
Rheumatol Int; 1984; 4(4):159-63. PubMed ID: 6333061
[TBL] [Abstract][Full Text] [Related]
40. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
Creyssel R; Gibaud A; Cordier JF; Boissel JP
Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]